NutraIngredients-Asia spoke to Raita Sasaki, assistant manager (overseas division) at JBSL during the Vitafoods Asia show, where he talked about plans for its overseas business.
Enzymes supplement that promote heart health is one of the company’s main portfolio.
Its Natural Super Kinase II supplement uses Nattokinase enzymes to prevent cardiovascular diseases (CVDs), such as reducing blood pressure and preventing thrombosis – a condition where blood clots are formed in the blood vessels.
Asked the reasons for focusing on the US market, he said that: “CVD is often said to be the leading cause of death in the US, and people in the US are very keen in disease prevention, and food supplements are used for disease prevention,” while huge market opportunities have drawn the company to enter the China market.
He also revealed some of the company’s newest R&D innovations, including the use of the Angelica Keiskei (Ashitaba) – a plant native to Japan to produce supplements that reduces visceral fats.
Watch the video to find out more.